ARCHIVES

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: NIH Funding For Shannon Awards To Fall, Eight Institutes Decide Not To Participate

August 13, 1993

DCT Board Approves Concepts For Three Radiation Research RFAs

March 6, 1987

Durant Suggests Six Efforts Needed For Survival Of Clinical Research

May 30, 1986

Hutchinson Center Receives NCI Grant For Immunotherapy Network

October 15, 2010

Avastin Approved To Treat Progressive Glioblastoma

May 29, 2009

Progress Reported On Zinder Recommendations for Virus Program

July 4, 1975